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Available data showed that there is at present a need for
an increasing research momentum towards the discovery
of an anti-retroviral drug, which could be used in the treat-
ment and control of the most deadly disease, such as
Acquired Immunodeficiency Syndrome (AIDS). Cur-
rently, Zidovudine (AZT), tamivudine (3Tc) and dideox-
yinosine (ddI) are the most commonly employed drugs
but with a minimal level of success. None of these availa-
ble orthodox drugs for the treatment of this epidemic
around the globe has so far provided the needed property
of a good drug. These drugs are very expensive and beyond
the reach of the average HIV patient in addition to their
being very toxic in nature. There is a strong belief in the
scientific community, that the active agent, which could
successfully combat the HIV/AIDS virus, might be con-
tained in medicinal plants. It is view that such isolate(s)
will be safe and cheap to the average AIDS patient. This
research is aimed at investigating whether the extracts
from some suspected ethnomedicinal savannah plants
possess any antiretroviral activity. Such plants would
include Ceratotheca sesamoides, Amaranthus viridis, Senna
occidentalis, Cassia singuena, Solanum americanum, Momor-
dica balsaminia, Jatropha curcas, Vernonia amygdalina, Lepta-
demia hastate, and Cassia tora. The plants extracts would be
administered to HIV infected laboratory cultured human
lymphocytes with a view to elucidating their potency and
efficacy as candidates worthy of repute for further toxico-
logical research towards the treatment of the disease.
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